SCID mice injected with PBMCs from human lupus patients produced less IgG when treated with anti-IL-10 antibodies [62] and similarly-treated mice showed less renal impairment after IL-10 blockade [63]. The gene discussed is IL10; the disease is systemic lupus erythematosus.